Urol. praxi. 2023;24(1):37-41 | DOI: 10.36290/uro.2023.017

Urolithiasis - metabolic disorders and conservative treatment

MUDr. Kateřina Vlachová
Urologické pracoviště při Geriatrické interní klinice 2. LF UK a FN Motol a Centru následné péče FN Motol, Praha

Urolithiasis with increasing incidence and prevalence is one of the diseases of civilization. High number of relapses initiated the improvement of lithiasis removal techniques, while emphasizing the importance of preventive and conservative treatment procedures. Metabolic examination can reveal the cause of urolithiasis in up to 97% of patients. We try to causally set up a possible conservative treatment. The patient's compliance with long-term treatment remains questionable.

Keywords: urolithiasis, metabolic disorders, urinary concrements.

Accepted: March 16, 2023; Published: March 21, 2023  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Vlachová K. Urolithiasis - metabolic disorders and conservative treatment. Urol. praxi. 2023;24(1):37-41. doi: 10.36290/uro.2023.017.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Resnick MI, PAK CY. Urolithiasis. A Medical and Surgical Reference. W.B.Saunders Company, 1990: 197 s.
    2. Moe OW. Kidney stones: Pathophysiology and medical management. The Lancet. 2006;367:333-344. Go to original source... Go to PubMed...
    3. Scales CD Jr, Smith AC, Hanley JM, et al. Prevalence of kidney stones in United States. Eur Urol. 2012;62:160. Go to original source... Go to PubMed...
    4. Petřík A. Diagnostika a terapie urolitiázy. Urol. praxi. 2011; 12(3):173-179.
    5. Ferraro PM, Curhan GC, D'Addesi A, et al. Risk of recurrence of idiopathic calcium kidney stones: analysis of data from the literature. J. Nephrol. 2017;30:227. Go to original source... Go to PubMed...
    6. Delvecchio FC, Preminger GM. Medical management of stone disease. Cur Opin Urol. 2002;13:229-233. Go to original source... Go to PubMed...
    7. Holmes RP, Goodman HO, Assimos DG. Contribution of dietary oxalate to urinary oxalate excretion. Kidney Int. 2001;59:270. Go to original source... Go to PubMed...
    8. Taylor EN, Curhan GC. Oxalate intake and the risk for nephrolithiasis. J Am Soc Nephrol. 2007;18:2198. Go to original source... Go to PubMed...
    9. Hildebrandt F, Sayer JA, Jungers P, et al. Nephronophthisis-medullary cystic and medullary sponge kidney disease.In: Diseases of the Kidney and Urinary tract, 8th ed, Schrier RW(Ed), Lippincot Williams &Wilkins, Philadelphia 2007, p478.
    10. Curhan GC, Tylor EN. 24uric acid excretin and the risk of kidney stones. Kidney Int. 2008;73:489. Go to original source... Go to PubMed...
    11. Curhan GC. Kidney stones in adults: Prevention of recurrent kidney stones. May 12,2022. Available from: http://www.uptodate.com.
    12. Curhan GC. Kidney stones in adults: Epidemiology and risk factors. Jun 27, 2022. Available from: http://www.uptodate.com.
    13. Goldfarb DS, Ferraro PM, Gambaro G. Medullaly sponge kidney. Feb 01, 2022. Available from: http://www.uptodate.com.
    14. Goldfarb DS, Ferraro PM, SA DJ, Baum MJ. Cystinuria and cystine stones. Jul 15, 2021. Available from: http://www.uptodate.com.
    15. Šebesta I. Poruchy metabolismu purinů. Available from: http:www.1.lf1.cuni.cz/text8.htm.

    Return to the content


    Urology for Practice

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.